Philips has collaborated with Al Qassimi Hospital, the largest MOHAP hospital in Sharjah and healthcare provider, to enhance patient and staff experience with the installation of the new Azurion 7 B20/12 Biplane image-guided therapy system and iApps.
With the help of this partnership, Philips said it continues to strengthen its long-term relationship with MOHAP, and Al Qassimi Hospital by supporting better health outcomes, lower cost of care, and improved patient and staff experience.
Dr. Arif Al Nooryani, CEO and head of Cardiac Centre, Al Qassimi Hospital, Sharjah said, “Al Qassimi hospital aims to improve the quality of cardiology and prevent cardiovascular diseases in the long run. Philips’ partnership with MOHAP allows us access to unique technology that will enhance the cath setting, and provide our staff with the ability to make fast and informed decisions on ground by controlling all relevant applications from a single touch screen at the table side, allowing us to cater to more patients per day while improving patient outcomes.”
Azurion Biplane system and iApps allows staff to perform procedures easily and confidently with a unique user experience, helping optimise lab performance and providing superior care. This allows seamless control of all relevant applications from a single touch screen at tableside, to help make fast, informed decisions in the sterile field.
By acquiring this technology and iApps in the Azurion biplane system, Al Qassimi hospital has upgraded its cath setting to enhance patient care and help expand its clinical services and outcomes.
According to an independently verified study at St. Antonius Hospital in The Netherlands, Philips Azurion enabled a 17% reduction in procedure times, a 12% reduction of in-lab patient preparation time, and a 28% reduction of post-procedure lab time, allowing them to treat 1 more patient per day.
Additionally, the Philips ClarityIQ is an X-ray imaging technology that provides high-definition image quality at a significantly lower dose across clinical areas, patients, and operators in comparison to the Allura Xper system.
In diagnostic coronary angiography, ClarityIQ technology reduces patient dose up to 75% while maintaining diagnostic image quality, compared to an Allura Xper system, and in EP procedures, ClarityIQ technology reduced patient dose up to 43%, compared to an Allura Xper system.
While in diagnostic and interventional neuro procedures, ClarityIQ technology reduces patient dose up to 62% and 65%, respectively, compared to an Allura Xper system.
With that being said, the Azurion X-ray system with ClarityIQ technology provides a new standard of image quality, by pushing the boundaries of ALARA (As Low As Reasonably Achievable) imaging.
Manoj Arora, business leader, Image Guided Therapy, Philips META said, “Our strategic partnership with MOHAP, and Al Qassimi hospital reinforces our purpose to continue to improve people’s health and well-being through meaningful innovation, as we look forward to seeing staff optimise lab performance and provide superior care to every patient.
“We see healthcare as a connected whole, from patient satisfaction, seamless staff experience and precise technology. We look forward to continue strengthening our partnership with MOHAP and strive for operational excellence.”
